These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31627708)

  • 1. Long Non-Coding RNAs - Current Methods of Detection and Clinical Applications.
    Moráňová L; Bartošík M
    Klin Onkol; 2019; 32(Supplementum 3):65-71. PubMed ID: 31627708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs and prostate cancer.
    Misawa A; Takayama KI; Inoue S
    Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
    Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
    Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?
    Deng J; Tang J; Wang G; Zhu YS
    Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28272371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Long Noncoding RNAs in Neoplasia: Special Emphasis on Prostate Cancer.
    Alahari SV; Eastlack SC; Alahari SK
    Int Rev Cell Mol Biol; 2016; 324():229-54. PubMed ID: 27017010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
    Xu YH; Deng JL; Wang G; Zhu YS
    Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of the Prostate Cancer Biomarker PCA3 with Electrochemical and Impedance-Based Biosensors.
    Soares JC; Soares AC; Rodrigues VC; Melendez ME; Santos AC; Faria EF; Reis RM; Carvalho AL; Oliveira ON
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46645-46650. PubMed ID: 31765118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
    Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
    Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
    Chandra Gupta S; Nandan Tripathi Y
    Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology.
    Zhang Z; Weaver DL; Olsen D; deKay J; Peng Z; Ashikaga T; Evans MF
    J Clin Pathol; 2016 Jan; 69(1):76-81. PubMed ID: 26323944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Roles of Long Non-coding RNAs as Novel Biomarkers in the Diagnosis and Prognosis of Prostate Cancer.
    Kan Y; Li B; Yang D; Liu Y; Liu J; Yang C; Mao L
    Discov Med; 2021; 32(165):29-37. PubMed ID: 35219354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the Long Non-Coding RNA NeSt and FOXCUT in Early Stages of Prostate Cancer Samples as Promising Biomarkers.
    Rostami S; Nabi M; Naghavi P; Mohammadzadeh N; Khalili A
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
    Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary RNA-based biomarkers for prostate cancer detection.
    Martignano F; Rossi L; Maugeri A; Gallà V; Conteduca V; De Giorgi U; Casadio V; Schepisi G
    Clin Chim Acta; 2017 Oct; 473():96-105. PubMed ID: 28807541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.